{"id":"NCT03482011","sponsor":"Eli Lilly and Company","briefTitle":"A Study to Evaluate the Efficacy and Safety of Mirikizumab (LY3074828) in Participants With Moderate-to-Severe Plaque Psoriasis","officialTitle":"A Multicenter Study With a Randomized, Double-Blind, Placebo-Controlled Induction Dosing Period Followed by a Randomized Withdrawal Maintenance Dosing Period to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-1","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-04-24","primaryCompletion":"2019-03-21","completion":"2020-01-16","firstPosted":"2018-03-29","resultsPosted":"2020-09-25","lastUpdate":"2020-09-25"},"enrollment":530,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis"],"interventions":[{"type":"DRUG","name":"Mirikizumab","otherNames":["LY3074828"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Mirikizumab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of mirikizumab in participants with moderate to severe plaque psoriasis.","primaryOutcome":{"measure":"Percentage of Participants With a Static Physician's Global Assessment of (sPGA) (0,1) With at Least a 2-point Improvement From Baseline","timeFrame":"Week 16","effectByArm":[{"arm":"Placebo Q4W","deltaMin":6.5,"sd":null},{"arm":"250 mg Miri Q4W","deltaMin":69.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":9},"locations":{"siteCount":69,"countries":["United States","Germany","Japan","Mexico","Poland","Puerto Rico","Russia","South Korea","Taiwan"]},"refs":{"pmids":["39073712"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":107},"commonTop":["Nasopharyngitis","Injection site pain","Upper respiratory tract infection","Headache","Arthralgia"]}}